Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ikena Oncology, Inc.

1.11
+0.0000
Post-market: 1.110.00000.00%16:00 EDT
Volume:138.59K
Turnover:154.85K
Market Cap:53.57M
PE:-1.09
High:1.17
Open:1.14
Low:1.07
Close:1.11
Loading ...
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 20, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Sep 22, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 06, 2023

Correspondence

Form CORRESP - Correspondence
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 01, 2023

Major Issues Report

Form 8-K - Current report
Jun 10, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Major Issues Report

8-K - Current report
Mar 14, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 19, 2022

Major Issues Report

8-K - Current report
Nov 28, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Major Issues Report

8-K - Current report